medigraphic.com
SPANISH

Revista Mexicana de Cirugía Pediátrica

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2014, Number 3

<< Back Next >>

Rev Mex Cir Pediatr 2014; 18 (3)

Infantile Hepatic Hemagioma treated with propanolol

Palacios AJM, Carrasquel VV, Jaramillo CE, Herrera OD
Full text How to cite this article

Language: Spanish
References: 8
Page: 130-138
PDF size: 385.94 Kb.


Key words:

Infantile hepatic hemangioma.

ABSTRACT

Introduction: Infantile hepatic hemangioma (IHH), It is considered a proliferative neoplasia, has a frequency of 10% in neonates with hepatic masses. The aim of this paper is to show the experience of the use of propranolol in patients with IHH in a 3rd level center.
Materials and Methods: This is a case series, in which we reviewed the clinical and radiological records of patients with HHI between 2007-2013, treated with VO Propanolol at 2.2 mg/kg/day. They were followed with ultrasound and computed tomography and electrocardiogram periodically, to evaluate their response.
Results: 7 children with IHH, 5 (71%) girls and 2 boys (29 %), mean age at diagnosis of 2.8 months were evaluated. 6 cases had palpable abdominal mass. We obtained reducing the size of lesions in 5 cases. In 2 cases, embolization was required. Treatment was administered for about a year. A single case of Kasabach - Merritt syndrome and subsequent multiple organ failure. He died 2 months after starting treatment. We have no recurrences until the date.
Discussion: Propranolol has proved useful as a treatment for patients with HHI; remain safe with few side effects.


REFERENCES

  1. Isaacs H. Fetal and neonatal hepatic tumors. J Pediatr Surg. 2007;42:1797–803.

  2. Falke DG, Exeni A, Vallone P, Boglione M, Serrani R, Rojas L, et al. Tumores benignos de higado. Revista de Cirugía Infantil. Buenos Aires, Argentina; 1994. p. 85–8.

  3. Leal N, Santamaría ML, Gámez M, Murcia J, Gutiérrez JCL, Larrauri J, et al. Hemangioendotelioma multifocal hepático infantil ¿ Es siempre un tumor benigno ? *. Cirugía Pediatr. 2004;17(1):8–11.

  4. Valencia JCD, Elvir CAC, Aguilar JMR, Solórzano S, Marín JPA, Ramírez RM. Tratamiento de hemangioma hepático con alfa interferón. Informe de un caso. Acta Pediátrica México. 1998;19(4):171–6.

  5. Sevilla EB, Viel VH. El propranolol revoluciona el tratamiento de los hemangiomas en la infancia The propranolol revolutionizes the treatment of hemangiomas in childhood. MEDISAN. 2013;17(7):2065–7.

  6. Richter GT, Friedman AB. Hemangiomas and vascular malformations: current theory and management. International journal of pediatrics. 2012. p. 645–78.

  7. Mhanna A, Franklin WH, Mancini AJ. Hepatic infantile hemangiomas treated with oral propranolol--a case series. Pediatr Dermatol. 2011;28(1):39–45.

  8. Kassarjian A, Zurakowski D, Dubois J, Paltiel HJ, Fishman SJ, Burrows PE. Infantile hepatic hemangiomas: clinical and imaging




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Cir Pediatr. 2014;18